Clinical Value Analysis of Single-Port Laparoscopic Surgery in the Treatment of Colorectal Cancer
Objective:To explore the clinical efficacy and prognostic analysis of single-port laparoscopic surgery for colorectal cancer patients.Methods:40 patients with colorectal cancer from May 2019 to May 2021 were selected and divided into a control group and an observation group using systematic sampling method,with 20 cases in each group.The observation group underwent single port laparoscopic surgery,while the control group underwent multi port laparoscopic surgery.Compare two groups of surgical related indicators,inflammatory factor indicators,immune function indicators,and postoperative recovery indicators.Results:The incision length was significantly shorter in the observation group than in the control group(P<0.05).However,there was no statistical difference in the amount of blood loss,the number of positive lymph nodes between the two groups(P>0.05).In the observation group,CRP and IL-6 were significantly lower at 1 day,3 days,and 5 days,and CD3+T cells,CD4+T cells,motin and gastrin were higher in the control group(P<0.05).Compared with the control group,the first implantation time in the observation group was relatively short(P<0.05),and there was no significant difference between the groups during the first exhaust time and hospitalization(P>0.05).Conclusion:The effectiveness and safety of single-port laparoscopic surgery in colorectal cancer patients,which can alleviate pain,protect the immune function of the body,control the postoperative inflammatory reaction,minimize the surgical trauma and the pain caused to the patient,and achieve the ideal treatment effect.
colorectal cancersingle-port laparoscopic surgeryclinical value